This Content Is Only For Subscribers
Africa (Commonwealth) _According to EU health commissioner Stella Kyriakides, the European Union (EU) would increase its assistance for vaccine manufacturing and healthcare in Africa in order to prepare the continent for any health problems in the future (5 February).
In remarks to reporters during a joint news conference held in Addis Ababa with top representatives from the African Union and the Africa Centers for Disease Control and Prevention, Kyriakides stated that the EU was dedicated to “fully-fledged African health sovereignty,”
Effective health systems are essential for combating pandemics like COVID-19. The EU supports the development of health systems in Africa by providing direct budgetary support, enhancing the ability of these nations to provide essential healthcare services to their populations.
In Burkina Faso, EU funding support assisted in removing barriers to essential health services, while in Rwanda, the EU assisted the country achieve universal healthcare through the implementation of a mandatory health insurance program.
One of the main responsibilities of budget support programs is to guarantee the population’s access to essential services in situations where governmental functions may be financially or physically unable to provide them. This is particularly true in low-income nations. West and Central African budget assistance programs have addressed these constraints by combining money for social service delivery with improved mobilization of domestic resources.
One important weapon for combating poverty and bolstering institutions is EU funding support. These nations today have stronger healthcare systems and are better prepared to handle medical emergencies like the COVID-19 pandemic. In order to support vulnerable nations and populations worldwide, particularly in Africa, the EU is now looking to collaborate with its member states and other international partners.
In addition to dealing with communicable diseases, Africa’s health industry also needs to cope with the rising prevalence of non-communicable disorders. Another difficulty, COVID-19, surfaced, but this time in a much younger population than previously. This protected it from realizing the worst predictions.
The regional institutions of Africa responded to the COVID-19 epidemic with great aplomb. This was observed on several fronts. African nations were better prepared to combat the HIV/AIDS pandemic It indicated that they were more equipped to combat infectious infections.
Following the Ebola epidemic of 2014–16, the African Union (AU) founded the Africa Centers for Disease Control and Prevention (Africa CDC). This organization was instrumental in administering a pandemic strategy that was based on a “commitment to coordinate, collaborate, cooperate, and communicate,” with assistance from the AU Ministers of Health.
The reaction was noteworthy and outstanding in that it aimed to establish robust coordination among many stakeholders by defining specific goals and objectives that were intended to “minimize duplication and ensure synergy.” An evidence-based approach to public health for improved COVID-19 prevention, monitoring, and treatment was another goal of the plan.
2020 saw the establishment of the Partnership to Accelerate COVID-19 Testing by the AU and Africa CDC. Because the continent is less linked, Africa has a lower number of “seeding events,” which has brought attention to the shortage of testing facilities. By August 2022, over 121 million tests had been performed and over two million COVID-19 cases—or 2.1% of all cases worldwide—had been found in AU Member States. Positive developments include the strengthening of testing capacities in forty-three nations.
A group of companies from South Africa, including Biovac, Afrigen Biologics and Vaccines, a network of universities, the World Health Organization (WHO), and the Africa CDC, created the first tech transfer hub in a significant effort to change vaccine access. These kinds of efforts drew strong political support.
Africa would benefit greatly from the robust institutional reactions to COVID-19 should other health emergencies, like as pandemics, arise in the coming years. The characteristics of the effective reaction are policy innovation, a robust partnership strategy, a demonstration of continental unity, political support, and an underappreciated will. With the use of mRNA technology, testing capacity and vaccine development have improved, giving Africa the resources it needs to more effectively tackle present and upcoming health issues.
In their paper A New Model for African Health, Mariana Mazzucato and Vera Songwe define health as a “public good,” wherein policy should be focused on advancing a “health for all” objective. They contend that initiatives frequently undertaken by organizations seeking profits at the expense of bolstering public health systems should be led by the public sector and solid alliances with public health actors, notably African multilaterals. According to this strategy, the state must be more capacitated and capable in order to benefit from encouraging research and development in addition to implementing the necessary legislative measures.
With the exception of South Asia, countries in Sub-Saharan Africa often spend much less on health as a proportion of GDP than other parts of the world.
Compared to upper-middle-class and high-income nations, governments in low- and lower-middle-income countries have less money to dedicate to health care. This has to be addressed, and a substantial amount of money—mostly from outside Africa—will be needed to fix the issues that jeopardize future attempts to respond to pandemics and other health emergencies that many believe are unavoidable. Approximately 3% of the total expenditures of African governments are allocated to health care. According to experts, 15% is required.
